Development to Market
Biotech IPO Market Thaws: Eikon, Agomab, SpyGlass and Veradermics Lead Billion-Dollar Revival
2026-02-09
Moderna and Recordati Form Strategic Alliance to Commercialize mRNA Therapy for Propionic Acidemia
2026-02-04
Facing a Patent Cliff, GSK Bets on a Potential Best-in-Class Food Allergy Biologic in $2.2B RAPT Deal
2026-01-20
JPM 2026 Reveals Biopharma’s High-Stakes Mix of IPO Risk, Market Turbulence, and Regulation
2026-01-19
Japan’s Eisai and U.S.-Based Nuvation Bio Secure Europe, Middle East Rights for Lung Cancer Drug in €195M Deal
2026-01-13
DISCO Pharmaceuticals and Amgen Ink Exclusive License Deal to Advance Surfaceome-Targeted Cancer Therapies
2026-01-07
South Korea’s Samsung Biologics Completes Spin-Off of Bioepis to Refocus on Global CDMO Strategy
2025-11-06



